- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03455647
Enhancing Milk Consumption for Improved Nutrition in Rwanda
March 9, 2021 updated by: RTI International
Enhancing Milk Quality and Consumption for Improved Income and Nutrition in Rwanda
This study is a mixed-methods cluster-randomized controlled trial in Rwanda designed to measure the impact of a dairy asset transfer program with or without nutrition education promoting the home consumption of dairy milk and other animal source foods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this research is to contribute to efforts for improving the consumption of milk in Rwanda.
It will do so by generating and communicating evidence on the nutritional benefits of including animal source food (ASF) in diets of young children and pregnant and lactating women through nutrition education.
The proposed project draws upon the work of a Government of Rwanda program - the One Cow per Poor Family (Girinka) program.
The Girinka program (2006 - present) is a country-wide program whose goal is to increase household income and reduce child malnutrition among poor households through livestock asset transfer.
The study has two main objectives.
First, researchers will measure the impact of a nutrition education/ASF promotion intervention on child and maternal nutritional status in households that have received a cow through the Girinka program.
Second, researchers will compare nutrition outcomes in the Girinka + nutrition education and Girinka only groups to individuals in households that are eligible for Girinka, but have not yet received a cow.
The nutrition education/ASF promotion intervention will be designed and overseen by a local organization and implemented through Government of Rwanda community health workers.
The main study outcomes are child height-for-age z-score, child milk consumption, and child dietary diversity.
The secondary outcomes are child weight-for-age z-score, child weight-for-height z-score, and maternal body-mass index.
The researchers plan to randomly assign all cells in two districts to receive the nutrition education intervention or no intervention.
The study will enroll a cohort of 687 mother-child pairs (229 per study arm).
The aim is to enroll children 12-17 months of age at baseline; however, if there are not adequate numbers of households that meet all other eligibility criteria, then the child age range will be expanded to 12-29 months of age at baseline.
The research team will conduct baseline and endline surveys to measure differences between the groups.
At endline, researchers will collect qualitative data from participants and community health workers in the intervention arm to triangulate with the survey findings.
Study Type
Interventional
Enrollment (Actual)
746
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Southern Province
-
Ruhango, Southern Province, Rwanda
- Ruhango District
-
-
Western Province
-
Nyabihu, Western Province, Rwanda
- Nyabihu District
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 49 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Arm 1:
- Household is located in an intervention cell
- Household received a cow under the government of Rwanda Girinka program before 2017
- Household contains a mother 18-49 years of age
- Household contains a child between the ages of 12 and 29 months at baseline
Arm 2:
- Household is located in a comparison cell
- Household received a cow under the government of Rwanda Girinka program before 2017
- Household contains a mother 18-49 years of age
- Household contains a child between the ages of 12 and 29 months at baseline
Arm 3:
-- Household is located in a comparison cell
- Household is eligible to receive a cow under the government of Rwanda Girinka program
- Household contains a mother 18-49 years of age
- Household contains a child between the ages of 12 and 29 months at baseline
Exclusion Criteria:
- Failure to meet inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ASF Promotion plus Girinka
Participants have received a cow from the government of Rwanda through the Girinka program and will receive an animal source food promotion intervention from the study.
|
Behavior change communication promoting the consumption of milk produced in the household and other optimal maternal and child nutrition practices.
The intervention will be implemented by government of Rwanda Community Health Workers.
|
No Intervention: Girinka only
Participants have received a cow from the government of Rwanda through the Girinka program and will not receive any intervention from the study.
|
|
No Intervention: Girinka eligible
Participants are eligible to receive a cow through the government of Rwanda Girinka program, but have not yet received a cow.
They will not receive any intervention from the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child height-for-age z-score (HAZ)
Time Frame: Baseline at study initiation
|
Measure child recumbent length in triplicate and age reported by mother.
HAZ will be calculated using the World Health Organization standard.
|
Baseline at study initiation
|
Child height-for-age z-score (HAZ)
Time Frame: Endline (approximately one year)
|
Measure child recumbent length in triplicate and age reported by mother.
HAZ will be calculated using the World Health Organization standard.
|
Endline (approximately one year)
|
Child dairy milk consumption
Time Frame: Baseline at study initiation
|
Measurement based on 24 hour recall of consumption amount
|
Baseline at study initiation
|
Child milk consumption
Time Frame: Endline (approximately one year)
|
Measurement based on 24 hour recall of consumption amount
|
Endline (approximately one year)
|
Child dietary diversity
Time Frame: Baseline at study initiation
|
Measurement based on 24 hour recall of consumption and calculated using the World Health Organization child dietary diversity indicator
|
Baseline at study initiation
|
Child dietary diversity
Time Frame: Endline (approximately one year)
|
Measurement based on 24 hour recall of consumption and calculated using the World Health Organization child dietary diversity indicator
|
Endline (approximately one year)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child weight-for-height z-score (WHZ)
Time Frame: Baseline at study initiation
|
Measurement based on recumbent length and body weight measured in triplicate.
WHZ will be calculated using the World Health Organization standard.
|
Baseline at study initiation
|
Child weight-for-height z-score (WHZ)
Time Frame: Endline (approximately one year)
|
Measurement based on recumbent length and body weight measured in triplicate.
WHZ will be calculated using the World Health Organization standard.
|
Endline (approximately one year)
|
Child weight for age z-score (WAZ)
Time Frame: Baseline at study initiation
|
Measurement based on weight measured in triplicate and age reported by mother.
WAZ will be calculated based on the World Health Organization standard.
|
Baseline at study initiation
|
Child weight for age z-score (WAZ)
Time Frame: Endline (approximately one year)
|
Measurement based on weight measured in triplicate and age reported by mother.
WAZ will be calculated based on the World Health Organization standard.
|
Endline (approximately one year)
|
Maternal body-mass index
Time Frame: Baseline at study initiation
|
Measurement based on weight and standing height.
|
Baseline at study initiation
|
Maternal body-mass index
Time Frame: Endline (approximately one year)
|
Measurement based on weight and standing height.
|
Endline (approximately one year)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Valerie Flax, PhD, MPH, RTI International
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 23, 2018
Primary Completion (Actual)
August 31, 2020
Study Completion (Actual)
August 31, 2020
Study Registration Dates
First Submitted
February 28, 2018
First Submitted That Met QC Criteria
February 28, 2018
First Posted (Actual)
March 6, 2018
Study Record Updates
Last Update Posted (Actual)
March 11, 2021
Last Update Submitted That Met QC Criteria
March 9, 2021
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0215801
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inadequate Child Growth
-
University of California, San FranciscoBill and Melinda Gates Foundation; Centre de Recherche en Sante de Nouna, Burkina...CompletedChild Mortality | Resistance Bacterial | Child Growth | Diversity of MicrobiomeBurkina Faso
-
Aga Khan UniversityUNICEFCompletedEarly Child Development and GrowthPakistan
-
University of Sao PauloCompletedGrowth | Contraception | Child Development | NewbornBrazil
-
Annamalai UniversityJohns Hopkins Bloomberg School of Public Health; Global Alliance for Improved... and other collaboratorsUnknownChild Development | Morbidity | Cognitive Development | Physical GrowthBangladesh
-
Queen Mary University of LondonBarts & The London NHS Trust; Child Growth Foundation; The Patients AssociationActive, not recruitingGrowth Disorders | Child Development | Stunting | Stunted GrowthUnited Kingdom
-
Erasmus Medical CenterRecruitingCrohn Disease | Child, Only | Biologic; InadequateNetherlands
-
Gazi UniversityNot yet recruitingChild Rearing | Growth and Development | Early Childhood Caries
-
Boston UniversityDepartment of Foregin Affairs and Trade, Australia; The Abdul Latif Jameel...Active, not recruiting
-
Marmara UniversityEnrolling by invitationParent-Child Relations | Growth Disorders | Feeding Behavior | Development, Child | GrandparentsTurkey
-
University of AarhusNot yet recruitingImmune System Diseases | Growth | Child Development | Vitamin D Supplementation
Clinical Trials on ASF promotion plus Girinka
-
Chinese University of Hong KongRecruiting
-
Dartmouth-Hitchcock Medical CenterRecruiting
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted DiseasesUnited States